NEW YORK (GenomeWeb News) – Definiens and Metamark Genetics today announced a multiyear agreement for use of Definiens' image analysis product for Metamark's prostate cancer prognostic test.

Under the terms of the deal, Definiens' Cognition Network Technology is being integrated with Metamark's ProMark test for the automatic classification of prostate tumor regions of interest and quantification of novel proteomic markers expressed in prostate biopsies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.